MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

25 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. -1.77 million declined by -108.35% from Rs. 21.20 millions.The Net Loss for the quarter ended March 2022 is Rs. -2.31 millions as compared to Net Profit of Rs. 6.19 millions of corresponding quarter ended March 2021Operating profit Margin for the quarter ended March 2022 slipped to -2.31% as compared to 6.19% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales -1.77 21.20 -108.35 21.62 0.15 14313.33 21.62 0.15 14313.33
Other Income 0.07 0.00 0.00 0.07 0.00 0.00 0.07 0.00 0.00
PBIDT -2.31 6.19 -137.32 -0.08 -16.03 -99.50 -0.08 -16.03 -99.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -2.31 6.19 -137.32 -0.08 -16.03 -99.50 -0.08 -16.03 -99.50
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -2.31 6.19 -137.32 -0.08 -16.03 -99.50 -0.08 -16.03 -99.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -2.31 6.19 -137.32 -0.08 -16.03 -99.50 -0.08 -16.03 -99.50
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 130.51 29.20 346.98 -0.37 -10686.67 -100.00 -0.37 -10686.67 -100.00
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..